whole brain radiotherapy for metastatic brain tumors, scalp sparing radiotherapy using IMRT: multi-insitutional study

whole brain radiotherapy for metastatic brain tumors, scalp sparing radiotherapy using IMRT: multi-insitutional study - scalp sparing whole brain radiotherapy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000058671

Enrollment

Registered

2025-08-01

Start date

2023-03-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

metastatic brain tumor

Interventions

Employing IMRT, reduce the dose to the scalp during whole brain radiotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with metastatic brain tumors who will undergo whole-brain radiotherapy using 3D treatment planning system at participating institutions Patients who have provided written consent to participate in the study Patients who are expected to survive for at least one month

Exclusion criteria

Exclusion criteria: Patients who have previously received radiation therapy to the head

Design outcomes

Primary

Measure	Time frame
The percentage of scalp hair preservation	—

Secondary

Measure	Time frame
The time to hair loss, time to hair regrow (median weeks) SF-8TM standard , Skindex29 before and after SS-IMRT Answer to the questionnaires	—

Countries

Japan

Contacts

Public ContactAnneyuko Saito

Juntendo University Urayasu Hospital Division of radiation oncology department of radiology

anne@juntendo.ac.jp047-353-3111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026